Samjin stocks gaining momentum

Published: 2008-05-09 06:57:00
Updated: 2008-05-09 06:57:00
Samjin Pharm is emerging as a darling of investors on the stock market on strong earnings prospects and solid fundamentals, analysts said.

Shares of Samjin have been enjoying momentum, spurred by development of novel antiviral pyrimidinedione derivatives co-developed by the U.S. based ImQuest ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.